Invitrotek ltd. Sti. (Istanbul, turkey) and pronto diagnostics ltd. (Tel aviv, israel) will collaborate in developing an assay, based on the targeted next generation sequencing to detect mutations in all thalassemia cases.
Delfia kits for 1st trimester preeclampsia (5-7% of pregnancies) tests will be developed with europium fluorometry & computerised robotic arms for accurate & fast testing. Verified clinically, and fda & ce registered, the kit will improve patient access & enhance sales for women's health.
An innovative lipid emulsion that provides in a single lipid all the necessary fatty acids in correct amounts and ratios, specifically tailored to the neonate's needs. By providing a balanced and complete parenteral nutrition for neonates, it will reduce the risks of complications.
The oral cavity is a unique organ and an entry gate to the whole body. The oralgerd project aims at developing a generic electronic intra-oral technological platform attached to a tooth for various applications such as gerd diagnostics, drug delivery, body health monitoring, and more.
Development of rapamycin eluting stents based on crystallization of the drug onto stent surface aims to develop a crystalline carrier-free coating of rapamycin onto stents which will keep the original metallic stent in the body after the drug has been released
This project aims at developing a novel point-of-care diagnostic device for the alzheimer's disease. Ihd's innovative diagnosis based on fluorescent probes and pixcell's unique microfluidics technology provide an optimal combination for developing such a device.
Development of an innovative endoscopic tool with a diameter of approximately 2 mm for use in tooth implantation procedures in the upper jaw.
A robotic cradle that moves head and neck gently along a predefined 3d course,reducing neck muscle contraction, alleviating pain & increasing the neck's range of motion. It is equipped with teach & repeat mode, which allows the therapist to tailor treatment according to each patient's needs.
This project aims to develop a multi-parametric functional imaging method by integrating signals from whole brain mapping via meg (finland) and simultaneous eeg-fmri (israel). The new tool will enable a concise functional network signaturing, thus improving brain-based diagnosis and treatment.
Samba is an integrated drug discovery project that combines state-of-the-art molecular biology, informatics and medicinal chemistry methods to develop optimized pre-clinical candidates against alzheimer disease acting as inhibitors of bace-1 and acetylcholinesterase.